Trials / Conditions / Relapsed B-Cell Non-Hodgkin Lymphoma
Relapsed B-Cell Non-Hodgkin Lymphoma
6 registered clinical trials studyying Relapsed B-Cell Non-Hodgkin Lymphoma — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma NCT07477366 | ImmunityBio, Inc. | Phase 2 |
| Recruiting | Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma NCT07125872 | ImmunityBio, Inc. | Phase 2 |
| Recruiting | A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma NCT06313957 | Peking University Cancer Hospital & Institute | Phase 1 |
| Recruiting | A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other An NCT04970901 | ADC Therapeutics S.A. | Phase 1 |
| Completed | Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell NCT03994913 | CARsgen Therapeutics Co., Ltd. | Phase 1 / Phase 2 |
| Terminated | Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL NCT02106091 | Affimed GmbH | Phase 1 |